NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for December 2024, as well as quarterly volumes, estimated revenue capture, number of listings, and index statistics for the quarter ended December 31, 2024 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics. About Nasdaq Nasdaq (Nasdaq: NDAQ) is a leading global technology company serving corporate clients, investment manag ...

About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...

CRANFORD, N.J., Jan. 8, 2025 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive agreements for the purchase of an aggregate of 743,496 shares of its common stock and accompanying warrants to purchase up to an aggregate of 743,496 shares of its common stock, at a purchase price of $4.035 per sha ...

Technology stocks were in fine form on the stock market in 2024, with the tech-laden Nasdaq Composite (^IXIC -1.89%) index clocking impressive gains of 28.6% last year following an even stronger jump of 43% in 2023.Historical trends indicate that the Nasdaq Composite could be on track to deliver more gains in 2025. In any year where the Nasdaq managed a 30%-plus gain overall, it averaged a 19% jump in the year that followed. Moreover, the Nasdaq averages a 17% return following a year in which it delivered r ...

MONTREAL and CHARLOTTE, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity awards, in the form of a total of 113,000 options (the “Options”) to purchase the Company’s common shares, pursuant to the Company’s 2021 Inducement Plan (the “Plan”), previously approved by the Company’s Compensation Committee and the Board of Directors, as a material inducement to employment of three new hires.  The Op ...

About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...

The Nasdaq Composite (^IXIC 1.24%) has been a great performing index, as it beat the broader S&P 500 (^GSPC 0.55%) in 2024 by rising 28.6% versus the S&P 500's 23.3%. It wouldn't surprise me to see those results again in 2025, but I think a few companies within the Nasdaq Composite can outperform the broader index in 2025.These stocks are Meta Platforms (META 4.23%), Alphabet (GOOG 2.50%) (GOOGL 2.65%), ASML (ASML 7.58%), PayPal (PYPL 2.20%), and MercadoLibre (MELI -1.90%). I think all five of these stocks ...

The CNN Money Fear and Greed index showed some easing in the overall fear level, while the index remained in the “Fear” zone on Monday.U.S. stocks settled mostly higher on Monday, with the S&P 500 and Nasdaq Composite recording back-to-back gains during the session.Chip stocks were among the top gainers of the session after Foxconn disclosed record revenue for the fourth quarter. Nvidia Corp. NVDA shares gained 3.4%, while Micron Technology Inc. MU jumped 10.5% on Monday.Among Monday's notable headlines, Th ...

STATEN ISLAND, N.Y., Jan. 6, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 2,463,058 shares of its common stock at a purchase price of $1.015 per share in a registered direct offering priced at-the-market under Nasdaq rules. In ...

Market Performance - US stocks traded higher with the Nasdaq Composite jumping over 200 points, the Dow up 0.08% to 42,765.84, and the S&P 500 rising 0.59% to 5,976.38 [1] - Information technology shares surged by 2.1% while utilities shares fell by 0.6% [1][2] Commodities - Oil traded down 0.1% to $73.92, gold fell 0.2% to $2,648.90, silver rose 1.9% to $30.640, and copper increased 2.4% to $4.1695 [6] Regional Markets - European shares gained with the eurozone's STOXX 600 up 0.95%, Germany's DAX 40 up 1.56%, France's CAC 40 up 2.24%, Spain's IBEX 35 up 1.34%, and London's FTSE 100 up 0.31% [7] - Asian markets closed lower with Japan's Nikkei 225 down 1.47%, China's Shanghai Composite down 0.14%, Hong Kong's Hang Seng down 0.36%, and India's BSE Sensex down 1.59% [8] Company News - Regional Health Properties, Inc. RHE shares surged 131% to $3.5824 after announcing a merger with SunLink in a $10 million preferred stock deal [10] - SciSparc Ltd. SPRC shares surged 108% to $1.10 following the publication of a European patent application for binge behavior [10] - fuboTV Inc. FUBO shares rose 235% to $4.83 after announcing a definitive agreement with Disney to combine Hulu with Fubo [10] - AEON Biopharma, Inc. AEON shares dropped 67% to $0.1884 after pricing a $20.0 million underwritten public offering [10] - BioLineRx Ltd. BLRX shares fell 42% to $0.1586 after reporting a $10 million registered direct offering [10] - Blue Hat Interactive Entertainment Technology BHAT shares dropped 41% to $0.0868 after pricing a $4.4 million registered direct offering [10]